Explorer
Know how is ZyCoV-D vaccine different from other
The phase II study of the vaccine ZyCoV-D had been conducted in over 1,000 healthy adult volunteers as part of the adaptive phase I/II dose escalation, multi-centric, randomised, double-blind placebo controlled study. The vaccine was found to be safe and immunogenic. Watch video to know more.
India
The Southern Rising Summit 2026: Human Intelligence vs AI, Can Artificial Intelligence Replace the Human Brain?
The Southern Rising Summit 2026: Manoj Kumar Reveals Coffee Academy Plan for Tribal Youth in Detail!
The Southern Rising Summit 2026: Shobana Kamineni on Apollo's Growth, Women in Leadership and Cycling 640 Km
The Southern Rising Summit 2026: Revanth Reddy Says True Development Means Equal Participation in Democracy
The Southern Rising Summit 2026: Revanth Reddy Picks Rahul Gandhi as Leader, Mocks KCR and BJP in Rapid Fire
View More
Trending News




















